Immunity and Viral Infections: Modulating Antiviral Response via CRISPR–Cas Systems
Viral infections cause a variety of acute and chronic human diseases, sometimes resulting in small local outbreaks, or in some cases spreading across the globe and leading to global pandemics. Understanding and exploiting virus–host interactions is instrumental for identifying host factors involved in viral replication, developing effective antiviral agents, and mitigating the severity of virus-borne infectious diseases. The diversity of CRISPR systems and CRISPR-based tools enables the specific modulation of innate immune responses and has contributed impressively to the fields of virology and immunology in a very short time. In this review, we describe the most recent advances in the use of CRISPR systems for basic and translational studies of virus–host interactions.
Citations by journals
1
|
|
Viruses
|
Viruses
1 publication, 10%
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
1 publication, 10%
|
Cells
|
Cells
1 publication, 10%
|
Frontiers in Microbiology
|
Frontiers in Microbiology
1 publication, 10%
|
Bioconjugate Chemistry
|
Bioconjugate Chemistry
1 publication, 10%
|
Current Research in Microbial Sciences
|
Current Research in Microbial Sciences
1 publication, 10%
|
BioMed Research International
|
BioMed Research International
1 publication, 10%
|
Critical Reviews in Microbiology
|
Critical Reviews in Microbiology
1 publication, 10%
|
Oral Oncology Reports
|
Oral Oncology Reports
1 publication, 10%
|
Medicinal Research Reviews
|
Medicinal Research Reviews
1 publication, 10%
|
1
|
Citations by publishers
1
2
3
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 30%
|
Elsevier
|
Elsevier
2 publications, 20%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
1 publication, 10%
|
American Chemical Society (ACS)
|
American Chemical Society (ACS)
1 publication, 10%
|
Hindawi Limited
|
Hindawi Limited
1 publication, 10%
|
Taylor & Francis
|
Taylor & Francis
1 publication, 10%
|
Wiley
|
Wiley
1 publication, 10%
|
1
2
3
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.